Phage Therapy Brazil: Universities vs Superbugs | AcademicJobs
Explore how USP, Unifesp, and Unicamp drive fagoterapia research against superbactérias, from Cepid B3 to KIDNAP Study, amid Brazil's AMR crisis.
No reviews yet. Be the first to rate Ariosvaldo!
Ariosvaldo Pereira dos Santos Junior is affiliated with the Instituto de Química at Universidade de São Paulo, where he completed his PhD in Biochemistry. His doctoral thesis, defended in 2025, focused on the molecular characterization of bacteriophages targeting multidrug-resistant Gram-negative bacteria, including detailed studies of phage LAFX isolated from a clinical strain of Pseudomonas aeruginosa.
He has conducted research on bacteriophages for potential applications in phage therapy and food safety, including work involving isolation and genomic analysis of phages active against resistant bacterial strains. Additional research interests include the evolutionary origins of DNA and RNA polymerases. He maintains a verified professional email at usp.br and has contributed to publications on phage biology and molecular evolution.
Explore how USP, Unifesp, and Unicamp drive fagoterapia research against superbactérias, from Cepid B3 to KIDNAP Study, amid Brazil's AMR crisis.
Photo by Mufid Majnun on Unsplash
Photo by Shubham Sharan on Unsplash
Photo by Shubham Sharan on Unsplash
Photo by Evan Marvell on Unsplash
Photo by Markus Winkler on Unsplash
Photo by Patrick Robert Doyle on Unsplash
Photo by Brandi Redd on Unsplash
Have a story or a research paper to share? Become an Expert Academic Contributor and publish your work on AcademicJobs.com.
Write news and research articles as a expert academic in your field publish your work on AcademicJobs.com
